INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE);UNIVERSITÉ DE NANTES
发明人:
Carole GUILLONNEAU,Ignacio ANEGON
申请号：
US15500615
公开号：
US20170226209A1
申请日:
2015.07.31
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to an isolated anti-CD45RC antibody for use in preventing or treating transplant rejection, autoimmune diseases, unwanted immune responses against proteins expressed in the course of gene therapy and/or therapeutic proteins, allergy as well as lymphoma or cancer which are associated with CD45RC+ cells. The invention relates to an isolated anti-CD45RC antibody for use in expanding and/or potentiating regulatory T cells.
